Empagliflozin, Linagliptin

Glyxambi 10 MG/5 MG Comprimidos Recubiertos con Pelicula

10 mg + 5 mg comprimido recubierto con películaSpainMarketedAuthorised 10 Jul 2017

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

GlyxambiEuropean UnionAuthorised

GlyxambiBrazil · Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda.Same brand
GlyxambiCanada · 25 MG + 5 MG · Tablet · Boehringer Ingelheim (Canada) LTD LteeSame brand
GlyxambiCanada · 10 MG + 5 MG · Tablet · Boehringer Ingelheim (Canada) LTD LteeSame brand
GlyxambiEuropean Union · Boehringer Ingelheim International GmbHSame brand
GlyxambiCroatiaSame brand
GlyxambiItaly · Compressa rivestita con film · Boehringer Ingelheim International GMBHSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Empagliflozin, Linagliptin

Glyxambi 10 MG/5 MG Comprimidos Recubiertos con Pelicula

10 mg + 5 mg comprimido recubierto con películaSpainMarketedAuthorised 10 Jul 2017

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

GlyxambiEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Glyxambi 10 mg/ 5 mg, filmomhulde tablettenNetherlands · Filmomhulde tablet · Boehringer Ingelheim International GmbH

Glyxambi 25 mg/ 5 mg, filmomhulde tablettenNetherlands · Filmomhulde tablet · Boehringer Ingelheim International GmbH

GlyxambiSaudi Arabia · Boehringer Ingelheim Pharma GmbH & Co. KG

Glyxambi Film-Coated Tablets 10 MG/5 MGSingapore · 10.00 mg + 5.00 mg · tablet, film coated · Boehringer Ingelheim Singapore Pte. LTD.

Glyxambi Film-Coated Tablets 25 MG/5 MGSingapore · 25.00 mg + 5.00 mg · tablet, film coated · Boehringer Ingelheim Singapore Pte. LTD.

GlyxambiUnited States · 10MG; 5MG, 25MG; 5MG · tablet · Boehringer Ingelheim

Empagliflozin and LinagliptinUnited States · 10MG; 5MG, 25MG; 5MG · tablet · Prinston Pharma INC

Empagliflozin; LinagliptinUnited States · 10MG; 5MG, 10MG/5MG, 25MG; 5MG … · tablet · Annora Pharma

empagliflozina + linagliptinaBrazil · Ems S/A

Packs

Pack	Code	Status
GLYXAMBI 10 MG/5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA 30 comprimidos	716517

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Empagliflozin, Linagliptin
Strength: 10 mg + 5 mg
Dosage form: comprimido recubierto con película
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 10 Jul 2017
Registration: 1161146005
Marketing authorisation holder: Boehringer Ingelheim International Gmbh
Procedure: EU centralised
Supply: Medicamento Sujeto A Prescripción Médica
EU number: EU/1/16/1146